Table 2 Clinical Characteristics of Participants According to SARS-CoV-2 Status
Clinical characteristics | Overall | R | SARS-CoV-2 | p-value | p-value* | |
|---|---|---|---|---|---|---|
Negative | Positive | |||||
N | 220 | 82 (37.3) | 138 (62.7) | |||
Arterial Blood Pressure | ||||||
Systolic Blood Pressure (mmHg) | 126 ± 16 | 0.02 | 119 ± 10 | 130 ± 18 | < 0.001 | < 0.001 |
Diastolic Blood Pressure (mmHg) | 75 ± 11 | 0.00 | 76 ± 9 | 75 ± 12 | 0.75 | 0.75 |
Vital Signs | ||||||
Temperature (°C) | 37.1 ± 1.1 | − 0.04 | 36.6 ± 0.5 | 37.5 ± 1.2 | < 0.001 | < 0.001 |
Pulse Rate | 92 ± 16 | − 0.16 | 94 ± 15.3 | 92 ± 17 | 0.31 | 0.77 |
Respiratory Rate | 22 ± 4 | − 0.04 | 20 ± 3 | 24 ± 4 | < 0.001 | < 0.001 |
Lipid Profile | ||||||
Total Cholesterol (mmol/l) | 4.0 ± 1.5 | − 0.10 | 4.6 ± 1.5 | 3.6 ± 1.4 | < 0.001 | 0.001 |
HDL-Cholesterol (mmol/l) | 1.0 ± 0.4 | 0.02 | 1.2 ± 0.4 | 0.8 ± 0.4 | < 0.001 | < 0.001 |
LDL-Cholesterol (mmol/l) | 2.4 ± 0.9 | − 0.06 | 2.7 ± 1.1 | 2.0 ± 1.0 | < 0.001 | 0.01 |
Triglycerides (mmol/l) | 1.6 ± 1.1 | − 0.07 | 1.4 ± 1.2 | 1.6 ± 1.0 | < 0.001 | 0.22 |
Glycemic Profile | ||||||
Glucose (mmol/l) | 9.3 ± 5.9 | − 0.03 | 6.0 ± 3.1 | 10.6 ± 6.8 | < 0.001 | 0.004 |
Vitamin D | ||||||
25(OH) D (nmol/L) | 57.5 ± 27.5 | – | 61.8 ± 22.8 | 55.0 ± 28.8 | 0.06 | 0.009 |
Inflammatory Markers | ||||||
Interleukin-6 (ng/ml) | 8.6 ± 11.2 | 0.01 | 6.6 ± 11.1 | 10.1 ± 11.1 | 0.004 | 0.008 |
C-Reactive Protein (µg/ml) | 21.9 ± 27.7 | 0.02 | 8.9 ± 10.5 | 42.9 ± 33.6 | < 0.001 | 0.002 |